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A hallmark of the adaptive immune response is rapid and robust activation upon rechallenge. In the current
issue of Immunity, van der Windt et al., (2012) provide an important link between mitochondrial respiratory
capacity and the development of CD8+ T cell memory.At one time, a rite of passage for success-
fully mastering basic biochemistry was
memorizing (at least long enough to recite
on an exam) the tricarboxylic acid (TCA)
cycle and associated pathways leading
to the generation of cellular ATP. The
current work of the Pearce lab is forcing
us to dust off our old Stryer and/or
Lehninger tomes (or is there an App for
that?) in order to reexamine the role of
these pathways in the development of
T cell memory.
Perhaps only rivaled by cancer cells,
lymphocyte activation requires an extra-
ordinary amount of energy and biochem-
ical substrates to facilitate expansive
cellular division (Fox et al., 2005). Similar
to cancer cells, T cells employ aerobic
glycolysis as a means of not only gener-
ating ATP but also providing substrates
for the generation of nucleic acids, fats,
and proteins. Indeed, an integral aspect
of CD28-mediated costimulation is not
only the elaboration of cytokines but also
the upregulation of glucose transporters
and the activation of biochemical path-
ways necessary to support these meta-
bolic demands (Frauwirth and Thompson,
2004). Along these lines, more recently,
a critical role for myc in the upregulation
of metabolic machinery necessary for
T cell activation has been described
(Wang et al., 2011). It was shown thatmyc-mediated transcription plays a crit-
ical role in the upregulation of genes
responsible for driving glycolysis but is
not essential for fatty acid oxidation (FAO)
and increasing the oxygen consumption
rate (OCR). Likewise, mammalian target
of rapamycin (mTOR) activation, which
has been shown to play an important role
in regulating CD4+ T effector cell genera-
tion, also plays an important role in the
expression of proteins involved in glycol-
ysis and glucose uptake (Powell et al.,
2011). Thus, it is clear that increases in
the metabolic machinery are not simply
the consequences of T cell activation but
actually play an integral role in promoting
T cell activation (Fox et al., 2005). Along
these lines, it has been shown that in
addition to failing to produce cytokines
upon rechallenge, anergic T cells fail to
express the metabolic machinery neces-
sary for T cell activation (Zheng et al.,
2009). In other words, the upregulation of
metabolic programs promotes the activa-
tion of T cells, whereas the inhibition of
such programs inhibits T cell function.
The initial antigen encounter leads to
a massive increase in the frequency
of CD8+ effector cells (Araki et al.,
2010). Following this expansion there
is a contraction phase that ultimately
results in the emergence of long-living
CD8+ memory T cells with the capabilityto respond rapidly and robustly upon
secondary rechallenge. Thus, memory
cells have a unique set of metabolic
demands. On the one hand, they must
employ pathways that facilitate their
long-term survival. On the other hand,
they must respond upon rechallenge
even more vigorously than naive T cells.
Van der Windt et al., (2012) in this issue
of Immunity sought to determine the
role of metabolism in regulating the
generation and maintenance of memory
cells. Their studies reveal that memory
CD8+ T cells possessed a markedly in-
creased mitochondrial spare respiratory
capacity (SRC) when compared to
effector T cells. SRC refers to the extra
mitochondrial ability in a cell to generate
energy under conditions of great demand.
That is, SRC can be thought of as
measuring how close a cell is to its
‘‘bioenergetic limit’’ (Nicholls, 2009).
The increase in SRC is dependent upon
interleukin-15 (IL-15) signaling, which is
already known to play a critical role in
the generation of CD8+ T cell memory.
The generation of memory CD8+ T cells
by exposure to IL-15 concomitantly led
to an increase in mitochondrial biogen-
esis. When compared to CD8+ effector
cells, memory cells were shown to
have increased mitochondrial membrane
potential and less superoxide production,36, January 27, 2012 ª2012 Elsevier Inc. 3
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Figure 1. Metabolic View of CD8+ Effector versus Memory Cells
From an immunologic perspective, upon activation CD8+ effector cells are short-lived killers able to
rapidly proliferate and secrete cytokines. Memory cells on the other hand are long-lived cells circulating
throughout the lymphoid tissue. Upon activation however, they too rapidly proliferate, secrete cytokines
and kill targets. The work of van der Windt et al. paints a contrasting metabolic portrait of these two
cell types. IL-2-promoted effector cells employ primarily glucose for fuel and aerobic glycolysis for
energy. IL-15-promoted memory cells demonstrate increased mitochondrial mass and employ oxida-
tive phosphorylation and fatty acid oxidation with increased expression of CPT1a. Overall, this results
in an increase in spare respiratory capacity, an increase in ATP, and a decrease in superoxide gener-
ation. The net result is that memory cells are built for long-term survival and poised for secondary
rechallenge.
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Previewswhich in turn contributed to their in-
creased long-term survival. Likewise,
while effector cells employed aerobic
glycolysis, memory cells switched to
oxidative phosphorylation as a means of
generating energy. Interestingly, upon
rechallenge, the memory cells reverted
quickly back to aerobic glycolysis. Fur-
thermore, IL-15-induced memory cells
were better prepared for this marked
increase in energetic demand in that
they had increased ATP upon re-stimula-
tion when compared to (IL-2 promoted)
T effector cells. Thus the increased SRC
in memory cells leads to increased ATP
upon rechallenge providing energy for
rapid and robust secondary activation.
Previously, this group had shown that
FAO promotes memory cell generation
(Pearce et al., 2009). Specifically, it was
shown that activated CD8+ T cells lacking
the TNF receptor TRAF6 fail to develop
into memory cells. This defect was linked
to defective AMP-activated kinase activa-
tion and subsequently mitochondrial
FAO. As such, in the current work, it was
hypothesized that IL-15-induced SRC
might be associated with an increase in4 Immunity 36, January 27, 2012 ª2012 Elsevmitochondrial FAO. Indeed, inhibiting
FAO with the drug etomoxir led to a
decrease in SRC in memory cells in both
the activated and resting state. Such find-
ings demonstrate the necessity for FAO
in generating energy in memory cells.
Inasmuch as IL-15 promoted the increase
in mitochondrial biogenesis, the ability of
IL-15 to regulate FAO was examined.
The rate-limiting step in the transfer of
fatty acids from the cytosol into the mito-
chondria is mediated by carnitine palmi-
toyltransferase 1 (CPT1a). Indeed, it was
found that IL-15 signaling led to the upre-
gulation of CPT1a expression. Function-
ally, silencing CPT1a led to decreases in
the OCR and SRC of memory cells while
overexpression of CPT1a led to increases
in OCR and SRC in both memory and IL-2
induced effector cells. Likewise, the over-
expression of CPT1a led to an increase in
survival of memory cells. Specifically, in
an in vivo model of infection, overexpres-
sion of CPT1a led to a mitigated contrac-
tion phase and thus an overall long-term
increase in memory cells. Thus, IL-15-
induced CPT1a is revealed as playing
a critical role in the development ofier Inc.CD8+ T cell memory. Interestingly, and
not entirely unexpectedly, the ability of
IL-15 to promote memory cell differentia-
tion was not exclusively related to CPT1a
expression. When CPT1a overexpressing
cells were transferred into IL-15-deficient
mice, they did not survive to the same
extent as bona fide memory cells. Thus,
the full extent of the IL-15-induced
signaling program that promotes the
generation of memory cells remains to
be determined. Likewise, the precise
connections linking FAO with T cell differ-
entiation as well as the role of the avail-
ability of various carbon sources on
guiding T cell differentiation and function
still need to be elucidated.
Overall, this work provides important
insight in terms of understanding the role
of metabolism in regulating immunologic
function (Figure 1). Activated effector cells
are anabolic, employing primarily glucose
as their carbon source and glycolysis as
a means of generating ATP (Fox et al.,
2005). Memory cells are catabolic, able
to metabolize fatty and amino acids
in addition to glucose and employ oxida-
tive phosphorylation (the TCA cycle) to
generate ATP. IL-15 promotes the gener-
ation of memory cells by promoting
mitochondrial biogenesis and the expres-
sion of CPT1a, the rate limiting enzyme
in FAO. Consequently, memory cells
generate less toxic superoxide radicals,
live longer, and generate increased
concentrations of ATP upon secondary
rechallenge. This study along with others
identifying the role of mTOR, estrogen
related receptor-alpha, and myc in regu-
lating lymphocyte metabolism suggests
that targeting metabolic pathways may
prove to be an effective means of phar-
macologically redirecting immunologic
responses (Michalek et al., 2011; Powell
et al., 2011; Wang et al., 2011). By inhibit-
ing specific metabolic pathways one
might on the one hand block undesirable
responses, for example in the case of
autoimmunity, and on the other hand
enhance immunity, for example in the
case of generating memory cells after
vaccination. Furthermore, the classifica-
tion of different cell types on the basis
of metabolic criteria may diverge from
phenotypic classifications based strictly
on immunologic criteria. As a little ‘‘fuel
for thought,’’ judging from metabolic
requirements it may turn out that regula-
tory T cells and CD8+ memory T cells are
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Innate lymphoid cells (ILCs) regulate the epithelial barrier function and immunity in the gut. How ILC numbers
are maintained is unknown. In this issue of Immunity, Qiu et al. (2012) report that the transcription factor aryl
hydrocarbon receptor controls survival and function of gut-residing ILCs.The aryl hydrocarbon receptor (Ahr) is a
ligand-dependent basic helix-loop-helix
transcription factor that resides in the
cytoplasm of many cell types in complex
with several proteins including heat
shock protein (Hsp) 90. The prototypic
Ahr ligand is the stable toxin 2, 3, 7, 8-
tetrachlorodibenzo-p-dioxin (TCDD). En-
dogenous ligands include the tryptophan
photoproduct 6-formylindolo-[3,2-b]-car-
bazole (FICZ). Also dietary ligands, such
as those contained in vegetables of the
family Brassicaceae, including broccoli,
can bind Ahr (Li et al., 2011). These
ligands enter the cells in a poorly charac-
terized manner and after binding to Ahr,
the complex translocates to the nucleus
where Ahr associates with the Ahr nuclear
transporter, Arnt. The Ahr-Arnt complex is
then able to induce transcription of an
array of target genes (reviewed in Veld-
hoen and Duarte, 2010). It was previously
found that Ahr is involved in differentia-
tion and function of T helper-17 (Th17)
cells and regulatory T (Treg) cells (Veld-hoen and Duarte, 2010). Interestingly,
Ahr is a key factor for production of inter-
leukin-22 (IL-22) by mouse Th17 cells
(Veldhoen et al., 2008) and human Th22
cells (Trifari et al., 2009). IL-22 regulates
immunity and tissue homeostasis at
barrier surfaces including the gut (Son-
nenberg et al., 2011). Recent work
demonstrates that innate lymphoid cells
(ILCs), which are dependent on the tran-
scription factor Rorgt, constitute a major
source of IL-22 (Spits and Di Santo,
2011). Rorgt+ ILCs, which includes
lymphoid tissue inducer (LTi) cells and
ILC22 (also called NK22 cells) are
members of a larger family of related
ILCs that include, in addition to Rorgt+
ILCs, conventional natural killer (NK) cells
and type 2 ILCs, with the latter dedicated
to the production of Th2 cytokines IL-5
and IL-13 (Spits and Di Santo, 2011). LTi
cells mediate lymph node formation
during embryonic development and after
birth these cells, perhaps in conjunction
with ILC22, are involved in formation ofcryptopatches (CP) and isolated lymphoid
follicles (ILFs) in the gut.
Three recent papers, including one in
the current issue of Immunity (Qiu et al.,
2012; Kiss et al., 2011; Lee et al., 2011),
identify Ahr as an important regulator of
homeostasis and IL-22 production by
Rorgt+ ILCs in the gut. Qiu et al. (2012)
has shown that Ahr deficiency caused
a marked decrease in the frequency of
LTi cells and ILC22 in the gut. The reduc-
tion of Rorgt+ ILCs was also seen in bone
marrow chimeras with mice receiving
Ahr/ stem cells as well as in Ahr/
Rag1/ mice that lack T cells indicating
that the effects of Ahr deficiency on
Rorgt+ ILC are cell intrinsic. This notion
was further supported by the observation
that specific deletion of Ahr in Rorgt-
expressing cells (including ILCs) has the
same consequences for Rorgt+ ILCs as
genetic ablation of Ahr in all mouse cells
(Lee et al., 2011).
The reduction of gut Rorgt+ ILC
numbers in Ahr-deficient mice occurred36, January 27, 2012 ª2012 Elsevier Inc. 5
